- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Grape King Bio Ltd (1707)
The Grape King Bio share price today is 106.00, view TW 1707 stock exchange data. Track the latest Grape King Bio share price with real-time updates on 1707 stock performance including market cap, day range, 52-week range and dividend yield. Access 1707 charts, earnings dates and analyst estimates to support your investment decisions.
Taiwan
Currency in TWD
106.00
-1.50(-1.40%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
106.00
108.00
52 wk Range
106.00
138.00
Trading near 52-week Low
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
106.00108.00
52 wk Range
106.00138.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1707 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
138.00
Upside
+30.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 138.00
(+30.19% Upside)
Earnings
Latest Release
11-05-2026
EPS / Forecast
1.36 / 1.42
Revenue / Forecast
2.16B / 2.27B
Compare 1707 to Peers and Sector
Metrics to compare | 1707 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship1707PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.2x | 17.9x | 12.0x | |
PEG Ratio | −1.30 | 0.64 | 0.03 | |
Price/Book | 1.6x | 1.9x | 1.5x | |
Price / LTM Sales | 1.5x | 1.6x | 0.9x | |
Upside (Analyst Target) | 28.4% | 8.9% | 24.9% | |
Fair Value Upside | Unlock | 15.2% | 13.1% | Unlock |
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Grape King Bio (1707) Share Price Today?
The Grape King Bio share price today is 106.00.
What is the current Grape King Bio (1707) share price and day range?
As of 19-05-2026, the Grape King Bio share price is 106.00, with a previous close of 141.00. The share price has ranged from 106.00 to 108.00 today, while the 52-week range spans from 106.00 to 138.00.
What Is the Grape King Bio Market Cap?
As of today, Grape King Bio market cap is 15.63B.
Does Grape King Bio Pay Dividends? What's The Current Dividend Yield?
The Grape King Bio dividend yield is 5.69%.
What Is the Grape King Bio (1707) Share Price Target?
The average 12-month share price target for Grape King Bio is 138.00, with a high estimate of 138 and a low estimate of 138. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +30.19% Upside potential.
What Is Grape King Bio's Earnings Per Share (TTM)?
The Grape King Bio EPS (TTM) is 8.41.
When Is the Next Grape King Bio Earnings Date?
Grape King Bio will release its next earnings report on 06-08-2026.
From a Technical Analysis Perspective, Is 1707 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Grape King Bio Trade On?
Grape King Bio is listed and trades on the Taiwan Stock Exchange.
What Is the Stock Symbol for Grape King Bio?
The stock symbol for Grape King Bio is "1707."
How Many Times Has Grape King Bio Stock Split?
Grape King Bio has split 4 times.
How Many Employees Does Grape King Bio Have?
Grape King Bio has 501 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.